Pediatric Cancer


The Loss of Logan Must Lead to A Greater Commitment to R&D into Pediatric Diffuse Intrinsic Pontine Glioma (“DIPG”)

More funding needs to go into pediatric diffuse intrinsic pontine glioma or “DIPG,” an untreatable brain cancer. When stories of three-year old children losing their life to such a condition surface, TrialSite News springs to action directing supporters to the family...

University of Alabama Investigator Earns FDA Grant for First-in-Human Viral Immunotherapy for Pediatric Brain Tumors

Dr. Gregory Friedman of the University of Alabama at Birmingham (UAB) received a three-year, $750,000 R01 grant from the U.S. Food and Drug Administration (FDA) for a Phase I immunotherapy clinical trial of engineered cold-sore (or herpes) virus G207 for the treatment...

Pin It on Pinterest